| Isoptin SR Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Isoptin SR 180 mg | tablet, extended release | oral | 1.0 each | OTC |
| Isoptin SR 240 mg | tablet, extended release | oral | 1.0 each | OTC |
| Isoptin SR 120 mg | tablet, extended release | oral | 1.0 each | OTC |
Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold ... - PharmaLive.com (press release)
... of FineTech Laboratories, Ltd. and a $9.2 million asset impairment charge related to Par's purchase of the new drug application (NDA) for Isoptin(R) SR. ...
Fri Sep 07 05:10:52 -0400 2007
Indian pharmas leverage authorised generics - Business Standard
Ranbaxy commercialised its first authorised generic product, Isoptin SR (Verapamil SR) in the US market two days ago. It hopes to garner a good share of the ...
Tue Aug 07 12:41:46 -0400 2007
Ranbaxy generics entry - Calcutta Telegraph
New Delhi, July 30: Ranbaxy Laboratories has commercialised its first authorised generic product, Isoptin SR — an anti-hypertensive agent — in the US market ...
Mon Jul 30 14:54:39 -0400 2007
verapamil hydrochloride - The hydrochloride form of Verapamil, which is a phenylalkylamine calcium channel blocking agent. Verapamil inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility. This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in some multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents. (NCI04)